These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

603 related items for PubMed ID: 24925027

  • 21. Malignant ascites-derived exosomes promote peritoneal tumor cell dissemination and reveal a distinct miRNA signature in advanced gastric cancer.
    Hu Y, Qi C, Liu X, Zhang C, Gao J, Wu Y, Yang J, Zhao Q, Li J, Wang X, Shen L.
    Cancer Lett; 2019 Aug 10; 457():142-150. PubMed ID: 31075288
    [Abstract] [Full Text] [Related]

  • 22. Kallikrein 4 expression is up-regulated in epithelial ovarian carcinoma cells in effusions.
    Davidson B, Xi Z, Klokk TI, Tropé CG, Dørum A, Scheistrøen M, Saatcioglu F.
    Am J Clin Pathol; 2005 Mar 10; 123(3):360-8. PubMed ID: 15716231
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Exosomal microRNA: a diagnostic marker for lung cancer.
    Rabinowits G, Gerçel-Taylor C, Day JM, Taylor DD, Kloecker GH.
    Clin Lung Cancer; 2009 Jan 10; 10(1):42-6. PubMed ID: 19289371
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Proteomic analysis of malignant ovarian cancer effusions as a tool for biologic and prognostic profiling.
    Davidson B, Espina V, Steinberg SM, Flørenes VA, Liotta LA, Kristensen GB, Tropé CG, Berner A, Kohn EC.
    Clin Cancer Res; 2006 Feb 01; 12(3 Pt 1):791-9. PubMed ID: 16467090
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Heat shock protein 90 is a putative therapeutic target in patients with recurrent advanced-stage ovarian carcinoma with serous effusions.
    Elstrand MB, Stavnes HT, Tropé CG, Davidson B.
    Hum Pathol; 2012 Apr 01; 43(4):529-35. PubMed ID: 21864883
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Upregulated expression of serum exosomal miR-375 and miR-1307 enhance the diagnostic power of CA125 for ovarian cancer.
    Su YY, Sun L, Guo ZR, Li JC, Bai TT, Cai XX, Li WH, Zhu YF.
    J Ovarian Res; 2019 Jan 22; 12(1):6. PubMed ID: 30670062
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Low serum exosomal miR-484 expression predicts unfavorable prognosis in ovarian cancer.
    Zhang W, Su X, Li S, Liu Z, Wang Q, Zeng H.
    Cancer Biomark; 2020 Jan 22; 27(4):485-491. PubMed ID: 32065786
    [Abstract] [Full Text] [Related]

  • 34. Profile of differentially expressed miRNAs in high-grade serous carcinoma and clear cell ovarian carcinoma, and the expression of miR-510 in ovarian carcinoma.
    Zhang X, Guo G, Wang G, Zhao J, Wang B, Yu X, Ding Y.
    Mol Med Rep; 2015 Dec 22; 12(6):8021-31. PubMed ID: 26497752
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Heparanase expression correlates with poor survival in metastatic ovarian carcinoma.
    Davidson B, Shafat I, Risberg B, Ilan N, Trope' CG, Vlodavsky I, Reich R.
    Gynecol Oncol; 2007 Feb 22; 104(2):311-9. PubMed ID: 17030350
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Ezrin Is Associated with Disease Progression in Ovarian Carcinoma.
    Horwitz V, Davidson B, Stern D, Tropé CG, Tavor Re'em T, Reich R.
    PLoS One; 2016 Feb 22; 11(9):e0162502. PubMed ID: 27622508
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 31.